Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Philippe Collet

Showing results (181-190 of 376) with videos related to

Pageof 38
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2010
Heparin or enoxaparin anticoagulation for primary percutaneous coronary interventionDavid Brieger, Jean-Philippe Collet, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|December 14, 2011
One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stentOlivier Barthelemy, Gérard Helft, Johanne Silvain, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2015
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacementDavide Capodanno, Gregory Y H Lip, Stephan Windecker, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
European Heart Journal|November 1, 2017
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Martin Björck, Marianne Brodmann, et al.
Open Heart|June 3, 2016
Switching between thienopyridines in patients with acute myocardial infarction and quality of careFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
European Heart Journal|June 4, 2005
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary EventsJean-Philippe Collet, Gilles Montalescot, Giancarlo Agnelli, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
International Journal of Cardiology|November 15, 2011
Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registryEtienne Puymirat, Nadia Aïssaoui, Jean-Philippe Collet, et al.
Archives of Cardiovascular Diseases|July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance projectAnouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Pageof 38

Showing results (181-190 of 376) with videos related to

Sort By:
Pageof 38
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2010
Heparin or enoxaparin anticoagulation for primary percutaneous coronary interventionDavid Brieger, Jean-Philippe Collet, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|December 14, 2011
One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stentOlivier Barthelemy, Gérard Helft, Johanne Silvain, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 21, 2015
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacementDavide Capodanno, Gregory Y H Lip, Stephan Windecker, et al.
Circulation. Cardiovascular Interventions|November 11, 2015
Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE studyStephen A O'Connor, Julien Amour, Anne Mercadier, et al.
European Heart Journal|November 1, 2017
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)Victor Aboyans, Martin Björck, Marianne Brodmann, et al.
Open Heart|June 3, 2016
Switching between thienopyridines in patients with acute myocardial infarction and quality of careFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
European Heart Journal|June 4, 2005
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary EventsJean-Philippe Collet, Gilles Montalescot, Giancarlo Agnelli, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
International Journal of Cardiology|November 15, 2011
Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registryEtienne Puymirat, Nadia Aïssaoui, Jean-Philippe Collet, et al.
Archives of Cardiovascular Diseases|July 27, 2010
Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance projectAnouk Meizels, David Messika Zeitoun, Vincent Bataille, et al.
Pageof 38